Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 29;9(1):7.
doi: 10.3390/proteomes9010007.

Insights into Mycobacterium leprae Proteomics and Biomarkers-An Overview

Sakshi Gautam  1   2 , Devesh Sharma  1 , Anjana Goel  2 , Shripad A Patil  1 , Deepa Bisht  1
Affiliations
Review

Insights into Mycobacterium leprae Proteomics and Biomarkers-An Overview

Sakshi Gautam et al. Proteomes. .

Abstract

Although leprosy is curable, the identification of biomarkers for the early diagnosis of leprosy would play a pivotal role in reducing transmission and the overall prevalence of the disease. Leprosy-specific biomarkers for diagnosis, particularly for the paucibacillary disease, are not well defined. Therefore, the identification of new biomarkers for leprosy is one of the prime themes of leprosy research. Studying Mycobacterium leprae, the causative agent of leprosy, at the proteomic level may facilitate the identification, quantification, and characterization of proteins that could be potential diagnostics or targets for drugs and can help in better understanding the pathogenesis. This review aims to shed light on the knowledge gained to understand leprosy or its pathogen employing proteomics and its role in diagnosis.

Keywords: biomarkers; diagnosis; leprosy; proteomics; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Sengupta U. Elimination of leprosy in India: An analysis. Indian J. Dermatol. Venereol. Leprol. 2018;84:131–136. doi: 10.4103/ijdvl.IJDVL_1070_16. - DOI - PubMed
    1. Rao P.N., Suneetha S. Current Situation of Leprosy in India and its Future Implications. Indian Dermatol. Online J. 2018;9:83–89. doi: 10.4103/idoj.IDOJ_282_17. - DOI - PMC - PubMed
    1. World Health Organization . Global Leprosy Update, 2018: Moving towards a Leprosy Free World. Volume 94. World Health Organization; Geneva, Switzerland: 2019. pp. 389–412. Weekly Epidemiological Record.
    1. Kundakci N., Erdem C. Leprosy: A great imitator. Clin. Dermatol. 2019;37:200–212. doi: 10.1016/j.clindermatol.2019.01.002. - DOI - PubMed
    1. Smith W.C., van Brakel W., Gillis T., Saunderson P., Richardus J.H. The missing millions: A threat to the elimination of leprosy. PLoS Negl. Trop. Dis. 2015;9:e0003658. doi: 10.1371/journal.pntd.0003658. - DOI - PMC - PubMed

LinkOut - more resources